TP53 and cervical cancer: Study by Zhu et al. (2021) reported that downregulation of the expression level of MDM2 results in upregulation of TP53 expression, resulting in the induction of cell cycle arrest and apoptosis in cervical cancer cells (Zhu et al., 2021).